Concepedia

Carlos Cruz-Castillo

CC

Statistics

Publications

2

Citations

530

H-Index

2

Active since

2022

Affiliations

Wellcome Sanger Institute(Current)

Open Targets

European Bioinformatics Institute

Carlos Cruz-Castillo is an author at Wellcome Sanger Institute specializing in drug discovery, business, and biomedical data science.

ORCID

Top concepts

Publications per year

2022–2024

2

Publications

2

The next-generation Open Targets Platform: reimagined, redesigned, rebuilt

David Ochoa, Andrew Hercules, Miguel Carmona et al. · Nucleic Acids Research · 2022 · 412 citations · Full text

, , +21

Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery

Annalisa Buniello, Dániel Süveges, Carlos Cruz-Castillo et al. · Nucleic Acids Research · 2024 · 118 citations · Full text

, , +14

1–2 of 2